The highest scores and thus the best synergistic effects were detected for the combination of azacitidine with A1155463, directly followed by the combination with ABT737, indicating that BCL-XL is an essential survival protein for JMML cells under azacitidine treatment. The gene discussed is BCL2L1; the disease is juvenile myelomonocytic leukemia.